Somatic Mosaicism in the Human Genome

Somatic mosaicism refers to the occurrence of two genetically distinct populations of cells within an individual, derived from a postzygotic mutation. In contrast to inherited mutations, somatic mosaic mutations may affect only a portion of the body and are not transmitted to progeny. These mutation...

Full description

Bibliographic Details
Main Authors: Freed, Donald, Stevens, Eric L., Pevsner, Jonathan
Format: Online
Language:English
Published: MDPI 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276927/
id pubmed-4276927
recordtype oai_dc
spelling pubmed-42769272014-12-30 Somatic Mosaicism in the Human Genome Freed, Donald Stevens, Eric L. Pevsner, Jonathan Review Somatic mosaicism refers to the occurrence of two genetically distinct populations of cells within an individual, derived from a postzygotic mutation. In contrast to inherited mutations, somatic mosaic mutations may affect only a portion of the body and are not transmitted to progeny. These mutations affect varying genomic sizes ranging from single nucleotides to entire chromosomes and have been implicated in disease, most prominently cancer. The phenotypic consequences of somatic mosaicism are dependent upon many factors including the developmental time at which the mutation occurs, the areas of the body that are affected, and the pathophysiological effect(s) of the mutation. The advent of second-generation sequencing technologies has augmented existing array-based and cytogenetic approaches for the identification of somatic mutations. We outline the strengths and weaknesses of these techniques and highlight recent insights into the role of somatic mosaicism in causing cancer, neurodegenerative, monogenic, and complex disease. MDPI 2014-12-11 /pmc/articles/PMC4276927/ /pubmed/25513881 http://dx.doi.org/10.3390/genes5041064 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Freed, Donald
Stevens, Eric L.
Pevsner, Jonathan
spellingShingle Freed, Donald
Stevens, Eric L.
Pevsner, Jonathan
Somatic Mosaicism in the Human Genome
author_facet Freed, Donald
Stevens, Eric L.
Pevsner, Jonathan
author_sort Freed, Donald
title Somatic Mosaicism in the Human Genome
title_short Somatic Mosaicism in the Human Genome
title_full Somatic Mosaicism in the Human Genome
title_fullStr Somatic Mosaicism in the Human Genome
title_full_unstemmed Somatic Mosaicism in the Human Genome
title_sort somatic mosaicism in the human genome
description Somatic mosaicism refers to the occurrence of two genetically distinct populations of cells within an individual, derived from a postzygotic mutation. In contrast to inherited mutations, somatic mosaic mutations may affect only a portion of the body and are not transmitted to progeny. These mutations affect varying genomic sizes ranging from single nucleotides to entire chromosomes and have been implicated in disease, most prominently cancer. The phenotypic consequences of somatic mosaicism are dependent upon many factors including the developmental time at which the mutation occurs, the areas of the body that are affected, and the pathophysiological effect(s) of the mutation. The advent of second-generation sequencing technologies has augmented existing array-based and cytogenetic approaches for the identification of somatic mutations. We outline the strengths and weaknesses of these techniques and highlight recent insights into the role of somatic mosaicism in causing cancer, neurodegenerative, monogenic, and complex disease.
publisher MDPI
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276927/
_version_ 1613170768278978560